XIAP and cancer: Since XIAP overexpression is directly related to many diseases such as cancer progression, autoimmune and neurodegenerative disease, it is an attractive target for novel therapeutic agents for the treatment of malignancy as a new way to counteract cancer and overcome drug resistance and poor clinical outcome (44).